Enamine | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Enamine is a privately owned chemical company established in 1991, specializing in the synthesis of building blocks and small molecular...
Enamine is a privately owned chemical company established in 1991, specializing in the synthesis of building blocks and small molecular weight compound libraries. The company supports pharmaceutical, biotech, and academic institutions with innovative chemistry solutions, offering services such as custom synthesis, compound library design, and lead optimization support. Enamine is recognized for having the world's largest reputable collection of chemical compounds tailored for the life sciences industry.
Website
Headquarters
Monmouth Junction, NJ
Size
1001-5000 employees
Industry
Chemical Manufacturing
Specialities
contract research organization, fine chemicals, small molecules supply
๐๏ธ Enamine Product and Pricing News โ
๐ Enamine CEO, Management and Leadership Team โ
โ๏ธ Enamine Alternatives and Competitors โ
๐ผ Enamine Hiring and Layoffs โ
๐ค Enamine Developer, Integration and Automation News โ
๐ Enamine Financials, Fundraising and Valuation News โ
๐๏ธ Enamine Product and Pricing News
- Enamine has introduced allenyl thianthrenium hexafluorophosphate, a stable reagent for efficient cross-coupling reactions, now available in stock.
- Enamine has expanded its Fast MADE Building Blocks catalog to include over 90 million molecules, offering synthesis and delivery of compounds within 2-3 weeks.
- Enamine has enhanced its Fast MADE Building Blocks service to deliver novel compounds within 2-3 weeks.
- Enamine chemists have developed a nortricyclene core available as a building block in their store.
- Enamine is commercially providing a special list of carboxylic acids used in a new machine learning workflow to enhance MAGL-inhibiting molecules.
- Enamine has established a set of ready-to-go image-based phenotypic assays for drug discovery.
- Enamine chemists have developed a new cyclobutane molecule, EN300-1936715, available at new.enaminestore.com.
- Enamine has made bicyclo[2.1.0]pentane, a previously rare scaffold, accessible for research.
๐ Enamine CEO, Management and Leadership Team
-
Chief Executive Officer
[email protected] -
Chief Executive Officer[email protected]
-
Executive Vice President[email protected]
โ๏ธ Enamine Alternatives and Competitors
- Sai Life Sciences |
- Snapdragon Chemistry |
- Liverpool ChiroChem |
- Nagi Bioscience |
- Examol |
- Cresset Group |
- Asinex |
- NANOSYN |
- Frontier Scientific |
- Selleck Chemicals |
- EnamineStore |
- MilliporeSigma |
- MOLBASE |
- Roche |
- Crown Bioscience |
- Santa Cruz |
- CIR62 |
- GSDI |
- Sto Brazil |
- Nicholls
๐ผ Enamine Hiring and Layoffs
- Enamine employees Yaroslav Poplavskyi, Vasyl Ripenko, Sergei Bova, Angelina Biitseva, Yurii V. Dmitriv, Andrei A. Tolmachev, Iryna V. Sadkova, and Pavel K. Mykhailiuk contributed to a study on a new reagent for methyl sulfones.
- Enamine introduced Volodymyr Kokhalskyi as the chemist behind their molecule of the week.
- Enamine is hiring a System Administrator/System Administrator Assistant for their team in Riga, Latvia.
๐ค Enamine Developer, Integration and Automation News
- Enamine has partnered with Schrรถdinger to provide ultra-large libraries of up to 6.5 billion compounds for virtual screening technologies.
- Enamine collaborated with the V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry to develop a synthesis of chiral spยณ-enriched chromanols using kinetic enzymatic resolution.
๐ Enamine Financials, Fundraising and Valuation News
- Enamine is one of the top five key players in the global Chemical Building Block market, contributing to a combined market share of over 29%.
People also viewed
- Key Organics |
- Deep MedChem |
- Reaxys |
- Schrรถdinger |
- eMolecules |
- Signifyd
